Purification and characterization of the human elongator complex
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Purification and characterization of the human elongator complex. / Hawkes, Nicola A.; Otero, Gabriel; Sebastiaan Winkler, G.; Marshall, Nick; Dahmus, Michael E.; Krappmann, Daniel; Scheidereit, Claus; Thomas, Claire L.; Schiavo, Giampietro; Erdjument-Bromage, Hediye; Svejstrup, Jesper Q.
In: Journal of Biological Chemistry, Vol. 277, No. 4, 25.01.2002, p. 3047-3052.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Purification and characterization of the human elongator complex
AU - Hawkes, Nicola A.
AU - Otero, Gabriel
AU - Sebastiaan Winkler, G.
AU - Marshall, Nick
AU - Dahmus, Michael E.
AU - Krappmann, Daniel
AU - Scheidereit, Claus
AU - Thomas, Claire L.
AU - Schiavo, Giampietro
AU - Erdjument-Bromage, Hediye
AU - Svejstrup, Jesper Q.
PY - 2002/1/25
Y1 - 2002/1/25
N2 - Human Elongator complex was purified to virtual homogeneity from HeLa cell extracts. The purified factor can exist in two forms: a six-subunit complex, holo-Elongator, which has histone acetyltransferase activity directed against histone H3 and H4, and a three-subunit core form, which does not have histone acetyltransferase activity despite containing the catalytic Elp3 subunit. Elongator is a component of early elongation complexes formed in HeLa nuclear extracts and can interact directly with RNA polymerase II in solution. Several human homologues of the yeast Elongator subunits were identified as subunits of the human Elongator complex, including StIP1 (STAT-interacting protein 1) and IKAP (IKK complex-associated protein). Mutations in IKAP can result in the severe human disorder familial dysautonomia, raising the possibility that this disease might be due to compromised Elongator function and therefore could be a transcription disorder.
AB - Human Elongator complex was purified to virtual homogeneity from HeLa cell extracts. The purified factor can exist in two forms: a six-subunit complex, holo-Elongator, which has histone acetyltransferase activity directed against histone H3 and H4, and a three-subunit core form, which does not have histone acetyltransferase activity despite containing the catalytic Elp3 subunit. Elongator is a component of early elongation complexes formed in HeLa nuclear extracts and can interact directly with RNA polymerase II in solution. Several human homologues of the yeast Elongator subunits were identified as subunits of the human Elongator complex, including StIP1 (STAT-interacting protein 1) and IKAP (IKK complex-associated protein). Mutations in IKAP can result in the severe human disorder familial dysautonomia, raising the possibility that this disease might be due to compromised Elongator function and therefore could be a transcription disorder.
U2 - 10.1074/jbc.M110445200
DO - 10.1074/jbc.M110445200
M3 - Journal article
C2 - 11714725
AN - SCOPUS:0037169503
VL - 277
SP - 3047
EP - 3052
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
SN - 0021-9258
IS - 4
ER -
ID: 331041790